AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04737538 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Dentrifrice
Description: Toothpaste containing sodium bicarbonate, sodium hyaluronate and sodium fluoride
Study NCT04737538 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Positive control dentifrice
Description: Dentifrice containing 67% w/w sodium bicarbonate and 0.221% w/w sodium fluoride
Study NCT04737538 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Negative control dentifrice
Description: Dentifrice containing 1100ppm fluoride as sodium fluoride (Crest Cavity Protection)
Study NCT05736679 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: In2Care EaveTube
Description: In2Care® EaveTubes (ETs) comprise 15 cm diameter, 20 cm long ventilation tubes with removable netting inserts that are placed in the wall under the roof of houses where they attract malaria mosquitoes at night, block them from entering the house, and contaminate them with a lethal dose of insecticide. In2Care® ET netting inserts have an electrostatically charged coating treated with bio-actives in powder form, which kills insecticide-resistant mosquitoes through high active ingredient dose transfer.
Study NCT05545670 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: not containing drugs
Study NCT05545670 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Allopurinol 300 MG
Description: a competitive xanthine oxidase inhibitor, reduces oxidative stress and attenuates bacterial translocation
Study NCT05709171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: PET/CT scan approximately 60 min after injection of 18F-FDG
Study NCT05709171 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-Dotatate
Description: PET/CT scan approximately 60 min after injection of 64Cu-Dotatate
Study NCT05449028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication scheme A
Description: Esomeprazole 40mg bid + amoxicillin 1g 12/12h + clarithromycin 500mg 12/12h + metronidazole 500mg 8/8h, for 14 days
Study NCT05449028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication scheme B
Description: Esomeprazole 40mg bid + amoxicillin 1g 12/12h + clarithromycin 500mg 12/12h + metronidazole 500mg 12/12h, for 14 days
Study NCT05449028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication scheme C
Description: Esomeprazole 40mg bid + bismuth subsalicylate 420mg 6/6h + metronidazole 375mg 6/6h + tetracycline 375mg 6/6h, for 10 days
Study NCT05449028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication scheme D
Description: Esomeprazole 40mg bid + amoxicillin 1g 12/12h for 7 days, followed by esomeprazole 40mg bid + clarithromycin 500mg 12/12h + metronidazole 500mg 12/12h for 7 days
Study NCT05449028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H. pylori eradication scheme E
Description: Esomeprazole 40mg bid + amoxicillin 1g 12/12h for 7 days, followed by esomeprazole 40mg bid + amoxicillin 1g 12/12h + clarithromycin 500mg 12/12h + metronidazole 500mg 12/12h for 7 days
Study NCT04518891 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Description: Cognitive functional therapy (CFT) is an intervention that deals with potentially modifiable multidimensional aspects of pain (e.g. provocative cognitive, movement and lifestyle behaviours). Treatment with CFT will be individualised, the physiotherapist will listen to the complete patient pain history and the intervention will be focused on individual needs. A detailed examination will be crucial in identifying the modifiable multidimensional mediators of pain and disability (provocative cognitive, pain, movement and lifestyle behaviors) of each participant.
Study NCT04518891 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham intervention
Description: Due to the impossibility of applying placebo exercise, the control intervention in this study will be based on successful reports of placebo intervention in patients with chronic low back pain in the literature (Placebo photobiomodulation + neutral talking control)
Study NCT06469008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-B16D1
Description: Administration by intravenous infusion for a cycle of 3 weeks.
Study NCT06481059 — intervention group
Intervention type: RADIATION
Intervention: Head and Neck cancer post-radiotherapy
Description: Head and Neck Cancer patients who received radiotherapy after 6 months
Study NCT05053672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ReOxy
Description: ReOxy therapy is a protocol which employs passive (the patient is at rest), short (up to 10 min) mild normobaric hypoxic exposures alternated with similar duration intervals of breathing hyperoxia (up to 5 min). The gas mixtures are supplied to a patient via facial mask on continued measuring of oxygenation status of the patients, lasting about 45 min in total per treatment session.~The hypoxic load will be individually adjusted, based on the results of a preliminary hypoxic test. The patient inhales air with low oxygen content (10-14%) at atmospheric pressure in a continuous mode through a mask withing 10-min.~During the ReOxy - treatment session, the software automatically adjusts the gas mixture switching, based on changes in physiological parameters (blood oxygen saturation and heart rate) in response to hypoxic and hyperoxic impact (biofeedback control).
Study NCT05053672 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham ReOxy
Description: Placebo treatment with 'sham' ambient air breathing to simulate ReOxy-therapy sessions. Placebo-mode breathing set visually similar to standard breathing set but have a mask with open intake valve. The masks are chosen in a way to provide maximum degree of similarity to reduce the risk of unblinding on the patient-side.
Study NCT06135662 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CAF + CTG
Description: Surgical techniques for mandibular gingival recession: coronally advanced flap + connective tissue graft. Participants undergo initial evaluations, including periodontal exams and digital imaging, followed by standardized pre-operative preparations. Post-surgery, uniform care includes pain management and oral hygiene instructions, with follow-ups to monitor healing and assess outcomes. Primary and secondary outcomes, like root coverage and patient-reported satisfaction, are consistently measured across groups. Standardized data collection and analysis procedures ensure reliable, comparable results, facilitating an effective comparison of the surgical methods' efficacy.
Study NCT06135662 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tunnel Technique + CTG
Description: Surgical techniques for mandibular gingival recession: tunnel technique + connective tissue graft. Participants undergo initial evaluations, including periodontal exams and digital imaging, followed by standardized pre-operative preparations. Post-surgery, uniform care includes pain management and oral hygiene instructions, with follow-ups to monitor healing and assess outcomes. Primary and secondary outcomes, like root coverage and patient-reported satisfaction, are consistently measured across groups. Standardized data collection and analysis procedures ensure reliable, comparable results, facilitating an effective comparison of the surgical methods' efficacy.
Study NCT05120362 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cream containing JAK Inhibitor
Description: The study drug is a cream containing JAK Inhibitor.
Study NCT04681859 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Flow Nasal Oxygen (HFNO) treatment
Description: Administration of High Flow Nasal Oxygen (HFNO) to patients who did not respond to standard low-flow oxygen therapy (non-rebreather mask on 15L/min). Adjust flow-rate and FiO2 as per standard HFNO treatment protocol.
Study NCT05069051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belimumab 200 MG/ML [Benlysta]
Description: Patients obtain belimumab treatment in combination with rituximab and venetoclax
Study NCT05069051 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard of care
Description: Patients obtain the standard of care: combination rituximab and venetoclax
Study NCT04681859 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy using OxyJet
Description: Administer CPAP to patients who did not respond to standard low-flow oxygen therapy (non-rebreather mask on 15L/min). CPAP initiated with FiO2 at 40% and a 10cm PEEP. Titrate PEEP to 15 cm if required. Deliver additional oxygen via secondary port if a higher FiO2 is required.
Study NCT06342817 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online mindfulness based meditation program
Description: Participants in the intervention group will attend 8 weekly online meetings lasting approximately 60 minutes each (generally structured in an initial 10 minutes for questions about the practices, 15-20 minutes of exposition on the central theme of the meeting, 5-10 minutes for class practice, 10-15 minutes for post-practice inquiry, 5 minutes for explanation of the week's informal practice and audios for daily practice). Audio in mp3 of the practice carried out at each meeting will be provided to maintain daily individual practice during the week. An online questionnaire related to weekly practices will also be left at the beginning of each meeting.
Study NCT05055024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mazindol
Description: Drug: NLS-2
Study NCT05173883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: injection ，CU-20401
Description: Subcutaneous injection，cohort A 6 sites
Study NCT04852185 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vi-TT
Description: Single-dose V-TT administered to children and adolescents between the ages of 9 months to 15 years.
Study NCT04852185 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MCV-A vaccine
Description: Single-dose of MCV-A vaccine (a meningococcal vaccine)
Study NCT06232135 — intervention group
Intervention type: OTHER
Intervention: CBCT scan
Description: analysis of the CBCT scan to assign a calcification stage to the subject's lower left third molar and accordingly calculate the estimated age of each subject
Study NCT05661825 — intervention group
Intervention type: OTHER
Intervention: phase II cardiac rehabilitation
Description: Phase II cardiac rehabilitation was provided in the the department of physical medicine and rehabilitation in Wan Fang Hospital. The programs are two times a week, one session for 30 minutes (30 sessions in total). The training programs are focused on aerobic training with bicycles. The training intensity is calculated with 40% to 80% oxygen consumption reserve from the result of cardiopulmonary exercise test. In case of safety, heart rate, blood pressure, EKG and rate of perceived exertion will be monitored during training.
Study NCT06142448 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cueing app
Description: All participants that are included come to the movement lab for the baseline measurement. The baseline measurement consists out of extensive clinimetrics (for example MDS-UPDRS) to identify patient characteristics. With the use of an objective gait assessment, the effectiveness of both internal and external cueing is determined. This will divide the participants in three groups; responders, non-responders and in between. Participants who clearly respond to either internal or external cueing (determined as the responders) are asked to apply the working form of cueing in daily life during the six-month follow-up. During this period the participants will use a mobile application that can provide them with a rhythmic auditory stimulus and records the use of this application.~After 6 months, both the responders and non-responders are asked to return to the lab for the follow up measurement in which the baseline measurement is repeated to evaluate the effect of long-term cueing.
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifasutenizol capsules
Description: 400 mg, BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabeprazole sodium enteric-coated tablets
Description: 20 mg, BID
Study NCT05242107 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 supplement group
Description: 35 Neonates were given Omega 3 in a dose of 40mg/kg/day (8), after establishment of full-feeding and for 2 weeks duration. Omega-300 (Montana pharmaceutical industry) capsule was used which contains 1000mg Omega 3 fatty acids.
Study NCT05242107 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Full feeding without receiving any supplementation group
Description: 35 full term Growth Restriction( IUGR) neonates who were followed up to full feeding without receiving any supplementation.
Study NCT05173883 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: injection ，placebo
Description: Subcutaneous injection，just one site
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabeprazole sodium enteric-coated tablets
Description: 20 mg, BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin Capsules
Description: 1 g, BID
Study NCT06494475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GBS-NN/NN2 vaccine
Description: Intramuscular injection.
Study NCT06494475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tdap vaccine
Description: Intramuscular injection.
Study NCT06494475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Intramuscular injection.
Study NCT05054140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMU-838
Description: IMU-838 tablets
Study NCT05054140 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching IMU-838
Description: Placebo matching IMU-838 tablets
Study NCT05698277 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Automated fetal cardiac function evaluation
Description: Evaluation of ultrasound parameters by automated algorithms.~Ultrasound assessed parameters are:~1. Pulsed wave Doppler Modified Left and Right Myocardial performance indices~2. Spatio-temporal image correlation Tricuspid, Mitral and Septal Annular Plane Systolic Excursion
Study NCT05533619 — intervention group
Intervention type: DRUG
Intervention: Proton pump inhibitor
Description: Inpatients using proton pump inhibitor
Study NCT05116501 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Whole-exome sequencing
Description: Whole Exome Sequencing (WES), as a comprehensive genetic test, will be used to identify changes in a patient's DNA that are causative or related to patient's low VWF levels.
Study NCT05116501 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Whole-exome sequencing
Description: Whole Exome Sequencing (WES), as a comprehensive genetic test, will be used to identify changes in a patient's DNA that are causative or related to patient's low VWF levels.
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin Capsules
Description: 1 g, BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin placebo tablets
Description: BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth potassium citrate placebo capsules
Description: BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin tablets
Description: 500 mg, BID
Study NCT05857163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth potassium citrate capsules
Description: 240 mg, BID
Study NCT05695599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole body vibration training
Description: 3 times per week of 20 to 30 minute sessions during 16 weeks of training
Study NCT05193578 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide, 1.34 mg/mL
Description: Semaglutide, 1.34 mg/mL
Study NCT05193578 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Semaglutide-Placebo
Study NCT04643106 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy
Description: During laparoscopic ovarian cystectomy, bleeding will be controlled by using a hemostatic agent (EVICEL®)
Study NCT04643106 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: suturing with barbed sutures during laparoscopic ovarian cystectomy
Description: During laparoscopic ovarian cystectomy, suturing of ovarian inner surface will be conducted to stop bleeding
Study NCT06078046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mind-body interventions
Description: Parallel randomized controlled trial
Study NCT05919953 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Immersive virtual reality neck exercises targeting relaxation, mobility, control, and speed of movement, using the Pico G2 4K headset.
Study NCT05919953 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapeutic education
Description: Several brochures will be given to participants. These brochures will cover the general principles of pain, the persistence of pain, tips for managing chronic non-specific pain, and the use of immersive virtual reality in the rehabilitation of chronic non-specific neck pain.~The information provided in the brochures will be discussed with the physiotherapist during the teleconsultations in order to individualize the therapeutic education.
Study NCT06628219 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Symani Surgical System
Description: The Symani Surgical System (Symani) is designed for open microsurgery procedures, featuring articulated and interchangeable instruments.
Study NCT06707337 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brief Self-compassion Program
Description: Brief Self-compassion Program will be held in a face-to-face hospital environment for the patients with colorectal cancer in the experimental group. This training program has been developed based on the concepts of Mindfulness-Based Compassionate Living and Mindfulness-Based Stress Reduction Programs. The content and topics of the sessions in the program are arranged according to the conceptual structure and flow of the mindfulness-based model. The training program was created in a certain flow, based on the introduction to a short self-compassion program (1 sessions), the importance of self-compassion and self-care in the cancer experience (1 sessions), a self-compassionate approach to challenging emotions and situations (1 sessions). There are 3 sessions in the program and the frequency of sessions is 3 times a week, and each session lasts approximately 45 minutes. The training program will be applied to 33 patients with colorectal cancer in the experimental group.
Study NCT06727448 — intervention group
Intervention type: OTHER
Intervention: SRQ questionnaire
Description: SRQ questionnaire administered at inclusion visit and 14 days after inclusion
Study NCT06727019 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low-level red-light
Description: 650-nm low-level red-light
Study NCT06727019 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine (0.01%)
Description: Atropine eye drops at concentration of 0.01%
Study NCT05128201 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: consolidative radiotherapy
Description: local consolidative radiotherapy for all metastatic lesion (30-45Gy/3-8F)
Study NCT06545019 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Informative Video on Perioperative Anxiety and Maternal Satisfaction
Description: An informative video designed to address potential sources of perioperative anxiety and dissatisfaction during elective lower segment caesarean section under spinal anaesthesia. The video provides details about the procedure, expected sensations, and management of discomfort to enhance patient understanding and reduce anxiety. It is administered to the intervention group of patients scheduled for elective caesarean section, allowing them to view it on their personal devices before the surgery.
Study NCT05599178 — intervention group
Intervention type: OTHER
Intervention: Ultrasound examination in early labor
Description: Combined trans-abdominal and trans-perineal ultrasound examination
Study NCT06116292 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The mobile application ESTOI for Asthmatic patients
Description: The mobile application ESTOI have various sections that can be managed and customized by the researchers to meet each patient's needs:~1. SYMPTOM CONTROL, it will record the ACT, TAI, the number of exacerbations, weight, and, depending on the case, symptom control for comorbidities.~2. RECOMMENDATIONS, it will provide patients with information needed to understand their condition, how to control it, and what to do in case of worsening symptoms.~3. YOUR TREATMENT, it will display personalized and update information about the patient's current asthma medication, including dosages and frequencies. There will be explanatory videos on how to administer the therapy and includes an action plan.~4. PEAK FLOW, the patient can record measurements using a Peak Flow Meter at home.~5. NUTRITIONAL PLAN, it will provide a daily dietary guide to enable individuals to adapt these tools and recommendations to their specific needs.~6. MESSAGING, it is a bidirectional contact area.
Study NCT06627894 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapist-Assisted Internet Cognitive-Behavioral Therapy for Depression
Description: Good Days Ahead (MindStreet, Inc.)
Study NCT06627894 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Depression education, symptom monitoring, and standard depression care
Study NCT06429891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: All study participants will undergo one 18F-FDG PET/CT scan.